We invite you to participate in an important clinical research trial evaluating the treatment of common warts with Candin, a licensed biologic that may enhance the immune system's ability to fight warts without destructive methods.
Study Purpose: This study aims to assess the effectiveness, safety, and tolerability of Candin in adolescents and adults with common warts. Participants will be randomly assigned to receive either Candin or a placebo.
Eligibility: We are seeking individuals aged 12 and older diagnosed with 3-20 common warts.
Compensation: Participants will receive:
$50 travel stipend for each visit.
$225 for visits 1-13, $300 for visit 14, and $450 for visit 15.
If you're interested in participating or would like more information, please contact us at 786-585-5774 or email us at vanessa@pediatricskinresearch.com
Thank you for considering this opportunity to contribute to dermatological research!
